NAVB (OTC)
NAVIDEA BIOPHARMS INC
—
Change: —
Prev close: —
Company Information
- Exchange
- OTC Link
- Sector
- —
- Industry
- —
- CEO
- —
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- —
- Employees
- —
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2023 (Q3)
|
$-0.02 | $0.00 | +0.0000 | +0.00% |
|
Dec 2022 (Q4)
|
$-0.11 | $0.00 | +0.0000 | +0.00% |
|
Sep 2021 (Q3)
|
$-0.08 | $-0.11 | +0.0322 | +28.70% |
|
Jun 2021 (Q2)
|
$-0.09 | $-0.08 | -0.0084 | -10.29% |
Financial Statements
| Revenues | $610.00 |
| Gross Profit | -$49.43K |
| Operating Expenses | $10.13M |
| Selling, General, and Administrative Expenses | $5.04M |
| Depreciation and Amortization | $108.18K |
| Research and Development | $5.09M |
| Operating Income/Loss | -$10.18M |
| Income/Loss From Continuing Operations After Tax | -$8.61M |
| Income/Loss From Continuing Operations Before Tax | -$8.61M |
| Net Income/Loss | -$1.18M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$1.00 |
| Net Income/Loss Attributable To Parent | -$1.39M |
| Net Income/Loss Available To Common Stockholders, Basic | -$1.39M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $2.04M |
| Preferred Stock Dividends And Other Adjustments | $2.04M |
| Basic Earnings Per Share | -$0.06 |
| Basic Average Shares | 60,828,376 |
| Assets | $5.70M |
| Current Assets | $4.50M |
| Inventory | $460.75K |
| Other Current Assets | $4.04M |
| Noncurrent Assets | $1.20M |
| Fixed Assets | $108.82K |
| Other Non-current Assets | $1.09M |
| Liabilities | $8.68M |
| Current Liabilities | $7.98M |
| Noncurrent Liabilities | $700.27K |
| Equity | -$2.98M |
| Equity Attributable To Noncontrolling Interest | $292.52K |
| Equity Attributable To Parent | -$3.27M |
| Liabilities And Equity | $5.70M |
| Net Cash Flow From Operating Activities | -$9.71M |
| Net Cash Flow From Operating Activities, Continuing | -$9.71M |
| Net Cash Flow From Investing Activities | -$701.11K |
| Net Cash Flow From Investing Activities, Continuing | -$701.11K |
| Net Cash Flow From Financing Activities | $995.75K |
| Net Cash Flow From Financing Activities, Continuing | $995.75K |
| Net Cash Flow | -$9.42M |
| Net Cash Flow, Continuing | -$9.42M |
| Comprehensive Income/Loss | -$1.18M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$1.18M |
| Other Comprehensive Income/Loss | $0.00 |